Chemed Corporation (CHE) Q4 FY25 Earnings Call

Management expects second-half recovery, but 2026 guidance depends on executing VITAS mix and Roto-Rooter billing improvements.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-27
Length57 minutes
EPS$5.92
EPS consensus$6.57
Revenue$639.3M
Revenue consensus$659.1M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q2 FY25

All CHE earnings · Back to CHE overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.